Study of Aripiprazole to Treat Children and Adolescents With Autism

Completed · Phase 2

Conditions studied: Autistic Disorder, Asperger Syndrome, Autism Spectrum Disorder

In brief

The purpose of this open label study in children and adolescents is to examine the acute and long-term effects of aripiprazole on problem behaviors associated with autism spectrum disorders and development in areas which appear to be affected by autism spectrum disorders.

Key facts

Study ID
NCT00619190
Run by
University of North Carolina, Chapel Hill
People needed
30
Starts
2006-01-01
Expected to finish
2012-06-01
Last updated by the study team
2014-03-26

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.